Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Anticoagulation Targets in Extracorporeal Life Support
2019-004125-24Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of heparin in heart failure (HF) and respiratory failure, sponsored by University Medical Center Groningen. Primary endpoint: Composite primary outcome. Started Jul 2020; status: active.
02
Drugs
heparin
03
Conditions
heart failure (HF)respiratory failure
Beyond the preview
Go deeper on 2019-004125-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004125-24.